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2Introduction
Rhabdomyosarcoma (RMS) is a mesenchymal malignant neo-
plasm that exhibits skeletal muscle cells with varying differ-
entiation degrees.1 RMS was first described by Weber in
1854, and accounts for 6% of all malignancies in children
under 15 years of age.2 It occurs most often in the head
and neck region, genitourinary tract, retroperitoneum
and, to a lesser extent, the extremities.3 In the head and
neck, the most frequently affected sites are orbit, parana-
sal sinuses, soft tissues of the cheek and the neck.4 Oral
RMS is rare, and when occurring, it is more frequent in
the soft palate.2741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights reserved
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E-mail address: brunocjham@yahoo.com.br (B. Correia Jham).Four basic histological patterns of RMS are recognized:
embryonal, botryoid, alveolar and pleomorphic. The embry-
onal type represents more than 70% of all cases.1 Histolog-
ically, embryonal RMS is characterized by a mixture of
pleomorphic and skeletal immature muscle cells, the
so-called rhabdomyoblasts. These cells have a distinctive
eosinphilic-rich cytoplasm and proliferate in a myxoid loose
stroma.5
The objective of this article is to describe a case of an
oral embryonal RMS in a very young patient with diagnosis
being only achieved through clinical, imaginological, histo-
pathological and immunohistochemical findings.
Case report
A four year-old black boy was referred to our service for
evaluation of a painless tumor on his face that had appeared.
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oral examination an extensive swelling on the left side of
the face was observed, with undefined limits, shiny and
smooth surface, reaching the mandible ramus, zygomatic
and infra-orbitary regions (Fig. 1(A)). During intra-oral
examination, a normal-colored mass was verified, with
smooth surface and fibrous consistency involving the buccal
mucosa, buccal aspect of the maxillary and mandibular
alveolar ridges, hard palate and extended towards the
occlusal aspect of the mandibular molars not allowing the
patient to occlude (Fig. 1(B)). Panoramic radiograph showed
an extensive radiolucid area of undefined limits comprising
the area from the mandibular body to the condyle with
reabsorption of the permanent tooth germ. Computerized
tomography revealed a large lesion in the maxillary sinus,
zygomatic and infra-orbitary space, including the base of
the skull (Fig. 2). In view of these findings, diagnostic possi-
bilities of Burkitt’s lymphoma, RMS and Ewing’s sarcoma
were hypothesized and an incisional biopsy was performed.
Hematoxylin and eosin-stained sections revealed a malig-
nant neoplasm of mesenchymal origin constituted of a loose
myxomatoid stroma exhibiting scattered pleomorphic cellsFigure 1 (A) Extra-oral aspect revealing extensive swelling
and assymetry on the left side of the patient’s face. (B) Intra-
oral aspect showing extensive mass involving the buccal
mucosa.
Figure 2 Large lesion invading maxillary sinus, zygomatic,
infra-orbitary space and base of the skull as shown in comput-
erized tomography.(Fig. 3(A) and (B)). In view of the histopathological findings,
immunohistochemical staining was performed through the
streptavidin-biotin technique using desmin (Clone DE-U-10,
Code D1033, Sigma–Aldrich Co., St. Louis, CA, USA) and
muscle specific-actin (Clone 1A4, Code A2547, Sigma–
Aldrich Co., St. Louis, CA, USA) monoclonal antibodies.
The neoplasic cells were strongly positive for both proteins
investigated, allowing the definitive diagnosis of embryonal
RMS (Fig. 3(C) and (D)). The patient was referred to an
Oncology Service and was treated with chemotherapy drugs
(vincristine, actinomycin D and cyclophosphamide). Partial
recovery occurred during the treatment’s initial phase.
Unfortunately, the patient passed away sixteen months
later, due to complications of the disease.
Discussion
RMS is a rare disease, more prevalent in young boys and
approximately 250 new cases are diagnosed each year in
the US.2 Peak age for occurrence is between two and six
years.6 Our patient was four year-old and within the most
frequent range.
Head and neck RMS is anatomically divided in two
categories: parameningeal (including nose, nasopharynx,
paranasal sinuses, mastoid region, infra-temporal and
pterygopalatine fossae and medium ear) and non-paramen-
ingeal (which include scalp, orbit, parotid gland, oral
cavity, oropharynx and larynx).7 In the oral cavity the most
common sites are tongue, palate and buccal mucosa.8,3 In
our patient, buccal mucosa, maxillary and mandibular alve-
olar ridges and hard palate were involved. Hence, the exact
primary site could not be determined.
Patients with parameningeal tumors may develop pain,
voice alterations, airway obstruction, epistaxis and cranial
Figure 3 (A) Low-power magnification (100·) of hematoxylin–eosin stain sections revealing malignant neoplasm of mesenchymal
origin. (B) High-power magnification (400·) of hematoxylin–eosin stain sections showing loose myxomatoid stroma with scattered
pleomorphic cells. (C) Positive immunohistochemical staining for desmin and muscle specific-actin. (D) Antibodies.
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interview epistaxis was reported.
Imaginological examination shows the size of the lesion,
its space relation and bone destruction extension.9 Through
computerized tomography and panoramic radiography, we
could determine that the lesion affected the mandible
body, condyle, maxillary sinus, zygomatic and infra-orbitary
space and base of the skull.
The diagnosis of RMS is confirmed through biopsy of the
primary tumor and an adequate amount of tissue should
be obtained. In the described case, we chose as biopsy spot
the left buccal mucosa.2 Microscopical examination oc-
casionally reveals striations in the muscle cells or rhabdo-
myoblasts.10 We observed in the described case spindle
pleomorphic cells. Final diagnosis can be obtained through
cytogenetic and/or immunohistochemistry.5 Intense stain-
ing for myoglobin, desmin and specific muscle-actin is pro-
portional to the rhabdomyoblast differentiation degree.7
In our case, we performed immunohistochemical studies,
using anti-desmin and specific muscle-actin antibodies,
and strong positivity was observed for both clones.
Prognosis of RMS is excellent in relation to other oral soft
tissues malignant lesions.3,11 However, it is influenced by
clinical staging and anatomic site of the tumor.3 Within his-
tological subtypes, alveolar type has the worst prognosis
whereas botryoid has the best.2 The described case was
classified as embryonal, and during physical examination
there were no signs of metastasis, which is a favorable find-
ing for prognosis. Nevertheless, our patient survived for
only sixteen months, since the tumor was already very
extensive.For the treatment of RMS, intensive doses of chemother-
apy in multi-drugs and multi-cycle regimens are used, so
that survival rates of children that develop head and neck
RMS can increase. Our patient was treated with a combina-
tion of vincristine, actinomycin D and cyclophosphamide.
Direct complications of chemotherapy are myelosuppresion,
thrombocytopenia and fever neutropenia, mucositis, nau-
sea, vomit and neurotoxicity.12
The Intergroup Rhabdomyosarcoma Study (IRS) classifies
RMS into four distinctive groups according to biological
behavior. Group I tumors have better prognosis whereas
groups III and IV have the worst. Studies show that around
50% of RMS patients die following chemotherapy13 or one
year after emission of histopathological diagnosis.1
In conclusion, we described clinical, imaginological, his-
tological and immunohistochemical aspects of a case of
intra-oral embryonal RMS. Although rare, soft tissue sarco-
mas should be included in the differential diagnosis of
intra-oral lesions, especially in children.Acknowledgements
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